Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Visualiza is a prominent eye care network and social enterprise headquartered in Guatemala, recognized for its innovative 'Visualiza Model' of sustainable healthcare delivery. The organization provides comprehensive ophthalmological services, including high-volume cataract surgery and specialized treatments for glaucoma and retinal diseases, using a cross-subsidization model to serve both private and low-income patients. Beyond clinical care, Visualiza operates a clinical research division that functions as a Contract Research Organization (CRO) and Site Management Organization (SMO), participating in international Phase 2 and 3 clinical trials for ophthalmic therapies. The organization is a key partner of the Seva Foundation and has received global acclaim from the Schwab Foundation and Ashoka for its contributions to preventing blindness in Central America. Visualiza's research capabilities focus on advancing treatments for conditions such as diabetic macular edema and age-related macular degeneration.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Visualiza.